Drugs for Arthrochalasia Ehlers-Danlos Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 143)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Rufinamide |
Approved |
Phase 4 |
|
106308-44-5 |
129228 |
Synonyms:
1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide
1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide
106308-44-5
AC-1429
AC1L2V8C
AKOS005145897
Banzel
Banzel, Rufinamide
Cgp 33101
CGP-33101
CHEMBL1201754
CID129228
D05775
E-2080
I06-1425
Inovelon
MLS001332513
|
MLS001332514
MolPort-005-942-441
NCGC00165883-01
NCGC00165883-02
NCGC00165883-03
R8404_SIGMA
RUF-331
Rufinamida
Rufinamide
Rufinamide (USAN/INN)
S1256_Selleck
SBB070637
SMR000857122
SYN-111
UNII-WFW942PR79
Xilep
ZINC00007782
|
|
2 |
|
Clonazepam |
Approved, Illicit |
Phase 4 |
|
1622-61-3 |
2802 |
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-nitro-5-(2-Chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-chloro-Phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
Chlonazepam
CID2802
Cloazepam
clonazepam
Clonazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
|
DB01068
DEA No. 2737
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
Landsen
Lktorivil
Lonazep
LS-34156
LS-34260
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4023
Ro 4-8180
Ro 54023
Ro 5-4023
Ro 5-4023/B-7
RO4023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
|
|
3 |
|
Clobazam |
Approved, Illicit |
Phase 4 |
|
22316-47-8 |
2789 |
Synonyms:
1-phenyl-5-methyl-8-chloro-1,2,4,5- tetrahydro-2,4-diketo-3H-1,5-benzodiazepine
1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine
1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1, 5-benzodiazepine
1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine
1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine
22316-47-8
4(3H,5H)-dione
5-24-08-00034 (Beilstein Handbook Reference)
7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione
7-chloro-1-Methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione
7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione
7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,
7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione
7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4-(3H,5H)-dione
AC1L1EGZ
AC-273
Ambap22316-47-8
BRN 0758410
C012255
C8414_SIGMA
Caastilium
CCRIS 7506
CHEBI:31413
CHEMBL70418
Chlorepin
CID2789
clobazam
Clobazam
Clobazam (JAN/USAN/INN)
Clobazam [USAN:BAN:INN]
Clobazamum
|
Clobazamum [INN-Latin]
Clorepin
D01253
DB00349
DEA No. 2751
EINECS 244-908-7
Frisium
H 4723
H-4723
HR 376
LM 2717
LM-2717
LS-34098
MolPort-003-940-848
Mystan
Mystan (TN)
NCGC00168249-01
nchembio747-comp39
Noiafren
NSC 336279
NSC336279
Odipam
Onfi
RU-4723
UNII-2MRO291B4U
Urbadan
Urbanil
Urbanyl
WLN: T67 GNV JVN IHJ CG G1 KR
ZINC00001175
|
|
4 |
|
Nitrazepam |
Approved |
Phase 4 |
|
146-22-5 |
4506 |
Synonyms:
1, 3-dihydro-7-nitro-5-Phenyl-2H-1,4-benzodiazepin-2-one
1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
1,3-dihydro-7-nitro-5-Phenyl-2H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
146-22-5
2,3-dihydro-7-nitro-5-Phenyl-1H-1,4-benzodiazepin-2-ON
2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-on
2,3-dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one
2,3-dihydro-7-nitro-5-Phenyl-1H-1,4-benzodiazepin-2-one
5-24-04-00344 (Beilstein Handbook Reference)
7-nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
7-nitro-1,3-dihydro-5-Phenyl-2H-1,4-benzodiazepin-2-one
7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
7-nitro-5-Phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-nitro-5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
AC1L1IBJ
AC1Q1XWD
AC-4537
AKOS002254707
Aliud brand OF nitrazepam
Aliud Brand of Nitrazepam
Allphar brand OF nitrazepam
Allphar Brand of Nitrazepam
Alodorm
Alphapharma brand OF nitrazepam
Alphapharma Brand of Nitrazepam
Alpharma brand OF nitrazepam
Alpharma Brand of Nitrazepam
Alter brand OF nitrazepam
Alter Brand of Nitrazepam
Apodorm
Apo-nitrazepam tablets BP
Atempol
Benzalin
Benzalin (TN)
Bio-0690
BRN 0757185
C07487
C15H11N3O3
Calsamin
Calsmin
CCRIS 1931
Cerson
CHEBI:111745
CHEMBL13209
ChemDiv1_022312
CID4506
CPD000058302
CSP Brand of Nitrazepam
CSP Brand OF nitrazepam
ct-Arzneimittel Brand of Nitrazepam
CT-Arzneimittel brand OF nitrazepam
D00531
D009567
DB01595
DDSA brand OF nitrazepam
DDSA Brand of Nitrazepam
DEA No. 2834
Dermatech brand OF nitrazepam
Dermatech Brand of Nitrazepam
Desitin brand OF nitrazepam
Desitin Brand of Nitrazepam
Dormalon
Dormicum
Dormicum (anticonvulsant)
Dormicum brand OF nitrazepam
Dormicum Brand of Nitrazepam
Dormin-5
dormo-Puren
Dormo-Puren
Dumolid
Eatan
Eatan N
EINECS 205-665-2
Epibenzalin
Epinelbon
Eunoctin
Eunoktin
Gerson
Hipnax
Hipsal
HMS2051F19
HMS650G04
I06-0805
Ibrovek
ICN brand OF nitrazepam
ICN Brand of Nitrazepam
Imadorm
Imeson
Imesont
InChI=1/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)
Ipersed
ISOPROPYLACETATE/NITRAZEPAM
|
LA 1
LA 1 (VAN)
LS-34311
Magadon
Megadon
Mitidin
MLS001304053
Mogadan
Mogadon
Mogadone
MolPort-000-302-259
MolPort-000-699-491
N3889_SIGMA
NCGC00159358-02
nchembio747-comp31
N-desmethylnimetazepam
N-Desmethylnimetazepam
Nelbon
Nelmat
Neozepam
Neuchlonic
neuraxpharm Brand of Nitrazepam
Neuraxpharm brand OF nitrazepam
Nitrados
Nitravet
Nitrazadon
Nitrazep
nitrazepam
Nitrazepam
Nitrazépam
Nitrazepam (JP15/USAN/INN)
Nitrazepam (TN)
Nitrazepam [USAN:INN:BAN:JAN]
Nitrazepam al
Nitrazepam AL
Nitrazepam-10
Nitrazepam-5
Nitrazepam-neuraxpharm
Nitrazepamum
Nitrazepamum [INN-Latin]
Nitrempax
Nitrenpax
Nitrodiazepam
Noctesed
Norgine brand OF nitrazepam
Norgine Brand of Nitrazepam
Novanox
NSC 58775
NSC58775
NSC-58775
Oprea1_476234
Pacisyn
Paxisyn
PDSP1_000120
PDSP2_000120
Pelson
Persopit
Pfleger brand OF nitrazepam
Pfleger Brand of Nitrazepam
Protea brand OF nitrazepam
Protea Brand of Nitrazepam
Radedorm
Relact
Remnos
Rhoxal-nitrazepam
Rhoxalpharma brand OF nitrazepam
Rhoxalpharma Brand of Nitrazepam
ro 4-5360
Ro 4-5360
ro 5-3059
Ro 5-3059
Ro 53-60
S 2000
SAM001246711
Sandoz nitrazepam
Scheurich brand OF nitrazepam
Scheurich Brand of Nitrazepam
Serenade
SMR000058302
Somitran
Somnased
Somnibel
Somnite
Sonebon
Sonebon Tofraniln A
Sonnolin
STK806322
Surem
Taurus brand OF nitrazepam
Taurus Brand of Nitrazepam
Trazenin
Unisomnia
United drug brand OF nitrazepam
United Drug Brand of Nitrazepam
Wernigerode brand OF nitrazepam
Wernigerode Brand of Nitrazepam
WLN: T67 GMV JN IHJ CNW KR
ZINC04311748
|
|
5 |
|
Stiripentol |
Approved |
Phase 4 |
|
49763-96-4 |
|
Synonyms:
1-(1,3-Benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol
4,4-Dimethyl-1-((3,4-methylenedioxy)phenyl)-1-penten-3-ol
Estiripentol
|
Stiripentol
Stiripentolum
|
|
6 |
|
Lamotrigine |
Approved, Investigational |
Phase 4 |
|
84057-84-1 |
3878 |
Synonyms:
3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine
3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-diamino-6-(2,3-Dichlorophenyl)-1,2,4-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-diamino-6-(2,3-Dichlorophenyl)-as-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine
84057-84-1
AC-10298
AC1L1GWT
BIDD:GT0794
Bio-0056
BW 430C
BW-430C
C047781
CHEBI:138727
CHEBI:6367
CHEMBL741
CID3878
CPD000058464
Crisomet
D00354
DB00555
Desitin Brand of Lamotrigine
EINECS 281-901-8
EU-0100688
EUR-1048
Faes Brand of Lamotrigine
GI 267119X
Glaxo Wellcome Brand of Lamotrigine
GlaxoSmithKline Brand of Lamotrigine
GW 273293
HMS2051C10
HMS2089M08
HMS2093P21
HSDB 7526
Juste Brand of Lamotrigine
L 3791
L3791_SIGMA
|
Labileno
Lamictal
Lamictal (TN)
Lamictal Cd
Lamictal CD
Lamictal ODT
Lamictal XR
Lamictin
Lamiktal
Lamitor
Lamotrigina
Lamotrigina [Spanish]
lamotrigine
Lamotrigine
Lamotrigine (JAN/USAN/INN)
Lamotrigine [USAN:INN:BAN]
Lamotriginum
Lamotriginum [Latin]
Lopac0_000688
Lopac-L-3791
LS-155249
MLS000069685
MLS000759486
MLS001077325
MolPort-003-666-744
NCGC00015605-01
NCGC00015605-02
NCGC00015605-06
NCGC00015605-08
NCGC00022936-02
NCGC00022936-04
NCGC00022936-05
NSC746307
SAM001246697
SMP2_000303
SMR000058464
STK628377
Tocris-1611
UNII-U3H27498KS
ZINC00013156
|
|
7 |
|
Topiramate |
Approved |
Phase 4 |
|
97240-79-4 |
5284627 |
Synonyms:
.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI)
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acid
2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acid
2,3:4,5-Di- O -isopropylidene-(beta)-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acid
2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acid
2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, .beta.
97240-79-4
AKOS000424547
beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate
BIDD:GT0854
BIDD:PXR0127
BRN 5988957
BSPBio_002306
C052342
C07502
C12H21NO8S
CBChromo1_000352
CHEBI:129573
CHEMBL220492
CID5284627
Cilag brand of topiramate
CPD000466325
D00537
DB00273
-D-fructopyranose deriv.
Epitoma
Epitomax
HMS1922H06
HMS2051L09
HMS2093D20
|
HSDB 7531
Janssen brand of topiramate
KS-1122
KW-6485
LS-187392
LS-69764
McN 4853
McN-4853
MCN-4853
MLS000759431
MLS001424070
MolPort-001-615-062
MolPort-002-885-869
NCGC00178714-01
Ortho brand of topiramate
RWJ 17021
RWJ-17021
RWJ-17021-000
S1438_Selleck
SAM001246601
SMR000466325
SPBio_000995
SPECTRUM1505801
Spectrum2_001128
STOCK1N-71037
T0575_SIGMA
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Tipiramic acid
TL8006021
Topamac
Topamax
Topamax (TN)
Topamax sprinkle
Topamax Sprinkle
Topamax, Topiramate
Topimax
Topina
topiramate
Topiramate
Topiramate (JAN/USAN/INN)
Topiramate (TPM)
Topiramate / Placebo
Topiramate [USAN:BAN:INN]
topiramate tablet
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
topiramatum [Latin]
Topiramic acid
Topomax
TOR
TPM
UNII-0H73WJJ391
USL-255
|
|
8 |
|
Tocopherol |
Approved, Investigational |
Phase 4 |
|
1406-66-2, 54-28-4 |
14986 |
Synonyms:
3,4-dihydro-2,7,8-Trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol
7,8-Dimethyltocol
7,8-dimethyltocolo-Xylotocopherol
Abortosan
adisseo Brand OF tocopherol
Alcala brand OF tocopherol acetate
Aliud brand OF tocopherol
Antioxidans e-hevert
Aquasol e
Arkopharma brand OF tocopherol acetate
AstraZeneca brand OF tocopherol acetate
Atarost brand OF tocopherol acetate
Ausrichter brand OF tocopherol
Auxina e
Balkanpharma brand OF tocopherol
Bayer brand OF tocopherol acetate
bio e
Biocur brand OF tocopherol acetate
biopto-e
Biosan
Bioweyxin
Blackmores brand OF tocopherol
Bottger brand OF tocopherol acetate
Cambridge laboratories brand OF tocopherol actetate
Dal e
Dal vita brand OF vitamin e succinate
Dal-e
Dal-vita brand OF vitamin e succinate
Davitamon
Dermorelle
Detulin
D-gamma-Tocopherol
DL-alpha-Tocopherol
DL-a-Tocopherol
DL-α-tocopherol
Dragees, vitamin-e
e Ferol
e Mulsin
e Vicotrat
e Vitamin e
Ecoro
e-Ferol
Elex verla
Embial
e-Mulsin
Ephynal
Eplonat
Equivit e
Eu rho brand OF tocopherol
EUNOVA vitamin e
Eusovit
e-Vicotrat
EVI-mirale, vitamin-e
Evion
e-Vitamin-ratiopharm
GNR Pharma brand OF tocopherol actetate
GNR-Pharma brand OF tocopherol actetate
Grace brand OF tocopherol
Grunwalder brand OF tocopherol
g-Tocopherol
Hervert brand OF tocopherol acetate
Heyl brand OF tocopherol acetate
Hydrovit e
ICN brand OF tocopherol acetate
Infirmarius rovit brand OF tocopherol
Infirmarius-rovit brand OF tocopherol
Internation animal health brand OF tocopherol acetate
Jenapharm brand OF tocopherol
Kentucky brand OF tocopherol
Kohler brand OF tocopherol
Lasar
Malton e
medphano Brand OF tocopherol acetate
Merck brand OF tocopherol acetate
Methyltocols
Micorvit e
MIP brand OF tocopherol acetate
Mowivit vitamin e
Mucos brand OF tocopherol acetate
Organon brand OF tocopherol acetate
O-Xylotocopherol
puncto e
Ratiopharm brand OF tocopherol
Richelet brand OF tocopherol acetate
|
Richtavit e
Riemser brand OF tocopherol
Roche nicholas brand OF tocopherol acetate
Rodisma med brand OF tocopherol
Rodisma-med brand OF tocopherol
Sanavitan S
Sanum kehlbeck brand OF tocopherol actetate
Sanum-kehlbeck brand OF tocopherol actetate
Schwarzhaupt brand OF tocopherol acetate
Sciencex brand OF tocopherol acetate
Scot tussin brand OF tocopherol acetate
Scot-tussin brand OF tocopherol acetate
Snow-e muscle, energy and feritility
Spondyvit
Stadapharm brand OF tocopherol
Steigerwald brand OF tocopherol acetate
Strathmann brand OF tocopherol
tocoferol
tocoferoles
Tocolion
Tocopa
Tocopharm
Tocopherol
tocophérol
Tocopherol ausrichter brand
Tocopherol balkanpharma brand
Tocopherol bayer
Tocopherol grace brand
Tocopherol grunwalder brand
Tocopherol infirmarius-rovit brand
Tocopherol kentucky brand
Tocopherol ratiopharm brand
Tocopherol rodisma-med brand
Tocopherol stadapharm brand
Tocopherol togal brand
Tocopherol twardy brand
Tocopherol verla brand
Tocopherol wiedemann brand
Tocopherol worwag brand
Tocopherols
Tocovital
Togal brand OF tocopherol
Togasan vitamin e
Troyapharm brand OF tocopherol acetate
Twardy brand OF tocopherol
Unique e
uno Vit
uno-Vit
UnoVit
Verla brand OF tocopherol
Veyx brand OF tocopherol
Vibolex
Vit e hydrosol
Vit. e stada
Vita e
Vita plus e
Vita-e
VitaE
Vitagutt vitamin e
Vitamin e al
Vitamin e dragees
Vitamin e evi mirale
Vitamin e gamma
Vitamin e MP
Vitamin e natur
Vitamin e sanum
Vitamin e suspension
Vitamin e, mowivit
Vitamin e, togasan
Vitamin e, vitagutt
Vitamin emp
Vitamin e-MP
Vitamin-e dragees
Vitamine e GNR
Vitamin-e evi-mirale
Vita-plus e
VitaPlus e
Vitazell
Wiedemann brand OF tocopherol
Wiedemann brand OF vitamin e succinate
Woelm brand OF tocopherol acetate
Worwag brand OF tocopherol
γ-tocopherol
|
|
9 |
|
Tiagabine |
Approved, Investigational |
Phase 4 |
|
115103-54-3 |
60648 |
Synonyms:
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotate
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotate
(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid
(R)-(-)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotate
(R)-(-)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
(R)-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, hydrochloride
(R)-Tiagabine
115103-54-3
A-70569-1
ABBOTT-70569-1
AC1L1TNE
AC1Q5R43
AC-7048
BIDD:GT0018
C07503
C20H25NO2S2
CHEBI:222170
CHEMBL1027
CID60648
D08588
|
DB00906
Gabitril
Gabitril (TN)
HSDB 7527
LS-114651
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
N-(4,4-Di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
NCGC00164626-01
NO 329
NO-328
NO-329
Tiagabina
Tiagabina [INN-Spanish]
tiagabine
Tiagabine
Tiagabine (INN)
Tiagabine [INN:BAN]
Tiagabine [INN]
Tiagabine, (S)-isomer
Tiagabinum
Tiagabinum [INN-Latin]
UNII-Z80I64HMNP
|
|
10 |
|
Levonorgestrel |
Approved, Investigational |
Phase 4 |
|
797-63-7, 17489-40-6 |
13109 |
Synonyms:
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one
(-)-Norgestrel
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one
)-Norgestrel
121714-72-5
13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE
13-b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one
13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
13-Ethyl-17-a-ethynyl-17-b-hydroxy-4-gonen-3-one
13-Ethyl-17-a-ethynylgon-4-en-17-b-ol-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
13-Ethyl-17-α-ethynyl-17-β-hydroxy-4-gonen-3-one
13-Ethyl-17-α-ethynylgon-4-en-17-β-ol-3-one
13-β-ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one
17-a-Ethinyl-13-b-ethyl-17-b-hydroxy-4-estren-3-one
17a-Ethynyl-13b-ethyl-3-oxo-4-estren-17b-ol
17-a-Ethynyl-13-ethyl-19-nortestosterone
17a-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17a-Ethynyl-18-homo-19-nortestosterone
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-13-ethyl-19-nortestosterone
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nortestosterone
17alpha-Ethynyl-18-homo-19-nor-testosterone
17-Ethynyl-18-methyl-19-nortestosterone
17-α-ethinyl-13-β-ethyl-17-β-hydroxy-4-estren-3-one
17-α-ethynyl-13-ethyl-19-nortestosterone
17α-ethynyl-13β-ethyl-3-oxo-4-estren-17β-ol
17α-ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17α-ethynyl-18-homo-19-nortestosterone
18,19-Dinor-4-pregnen-20-yn-3-one
18-Methyl-17-a-ethynyl-19-nortestosterone
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methyl-17-α-ethynyl-19-nortestosterone
18-Methylnorethisterone
4222-79-1
6533-00-2
72-HOURS
797-62-6
797-63-7
AC1L211U
AC1Q6OEV
Alcala brand OF levonorgestrel
alpha-Norgestrel
Aventis pharma brand OF levonorgestrel
BAY 86-5028
BAY86-5028
Berlex brand OF levonorgestrel
BIDD:PXR0194
Bio-0595
BPBio1_000932
BRD-K35189033-001-03-0
BRN 2391114
BSPBio_000846
C08149
C08153
Capronor
CCRIS 6525
CCRIS 9033
Cerazet
CHEBI:44593
CHEBI:6443
CHEMBL1389
CID13109
component of Lo/ovral
CPD000059117
D Norgestrel
D(−
d(-)-Norgestrel
D(-)-Norgestrel
D-(-)-Norgestrel
D00950
D00954
DB00367
DB00506
dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone
dl-Norgestrel
D-Norgestrel
Duofem
E-Gen-C
EINECS 212-349-8
EINECS 229-433-5
FH 122-A
Follistrel
Hexal brand OF levonorgestrel
HMS1570K08
HMS2051M08
HMS2090O06
HRA brand 1 OF levonorgestrel
HRA brand 2 OF levonorgestrel
HSDB 3595
HSDB 6483
Jadelle
L Norgestrel
Ld norgestrel
LD norgestrel [French]
Levlen
Levlen ED
Levonelle
Levonelle, D-Norgestrel, Levonova, Levonorgestrel
Levonorgestrel
Lèvonorgestrel
Levonorgestrel (JAN/USP/INN)
Levonorgestrel [USAN:INN:BAN]
Levonorgestrel alcala brand
|
Levonorgestrel berlex brand
Levonorgestrel hexal brand
Levonorgestrel implants
Levonorgestrel paladin brand
Levonorgestrel wyeth brand
Levonorgestrelum
Levonorgestrelum [INN-Latin]
Levonova
Levora-21
Levora-28
LMST02030119
L-Norgestrel
LO/Ovral
Logynon ED
LS-62083
LS-62084
Methylnorethindrone
Microgest ED
Microgyn
Microgynon 21
Microgynon 28
Microgynon 30 ED
Microgynon CD
Microlut
Microlution
Microluton
Microval
Minivlar 30
Mirena
Mirena (TN)
MLS000069491
MLS000759484
MLS001074069
MolPort-002-510-453
Monofeme 28
Monovar
N2260_FLUKA
N2260_SIGMA
NCGC00159349-02
NCGC00159349-03
Neogest
Neogynon 21
Nordet
Nordette 21
Nordette 28
Norgeston
norgestrel
Norgestrel (JP15/USP/INN)
Norgestrel [Progestins]
Norgestrel [USAN:BAN:INN:JAN]
Norgestrel [USAN:INN:BAN:JAN]
Norgestrel-(-)-D
Norgestrelum
Norgestrelum [INN-Latin]
NorLevo
Norplant
NORPLANT
Norplant (TN)
Norplant 2
Norplant II
Norplant System in Plastic Container
Norplant2
Norplant-2
NSC744007
Ovoplex 30-150
Ovral-Lo
Ovranette
Ovrette
Ovrette (TN)
Paladin brand OF levonorgestrel
Plan b
Plan B
Postinor
Postinor-2
Prestwick_109
Prestwick0_000773
Prestwick1_000773
Prestwick2_000773
Prestwick3_000773
Preven
Rigevidon 21+7
S1727_Selleck
SAM001246694
Schering brand 1 OF levonorgestrel
Schering brand 2 OF levonorgestrel
Schering brand 3 OF levonorgestrel
SH 70850
SH 850
SMR000059117
SMR000653526
SOH-075
SPBio_002785
Stediril 30
Tetragynon
Triagynon
Triciclor
Trifeme 28
Trigoa
Tri-Levlen 21
Trinordiol 21
Trinordiol 28
Triphasil 21
Triphasil 28
Triquilar ED
Trivora
UNII-3J8Q1747Z2
UNII-5W7SIA7YZW
Vikela
Women's capital brand OF levonorgestrel
Wy 3707
Wy-3707
Wy-5104
Wyeth brand OF levonorgestrel
ZINC03814395
|
|
11 |
|
Ivermectin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
70288-86-7 |
6474909 |
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
I8898_SIGMA
|
Ivermectin
IVERMECTIN
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick_516
Prestwick2_000156
Prestwick3_000156
S1351_Selleck
SMR000857211
|
|
12 |
|
Phenobarbital |
Approved, Investigational |
Phase 4 |
|
50-06-6 |
4763 |
Synonyms:
11097-06-6
46755-67-3
50-06-6
57-30-7 (mono-hydrochloride salt)
5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione
5-Ethyl-5-phenylbarbitate
5-Ethyl-5-phenylbarbitic acid
5-Ethyl-5-phenylbarbituric acid
5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione
5-Phenyl-5-ethylbarbitate
5-Phenyl-5-ethylbarbitic acid
5-Phenyl-5-ethylbarbituric acid
AC1L1IWE
Acid, phenylethylbarbituric
Acido 5-fenil-5-etilbarbiturico
Acido 5-fenil-5-etilbarbiturico [Italian]
Adonal
aephe nal
Aephenal
Agrypnal
AI3-02726
AKOS000605404
Amylofene
Antrocol
Aphenylbarbit
Aphenyletten
Arco-Lase Plus
Austrominal
barbapil
barbellen
barbellon
Barbenyl
barbilehae
Barbilehae (barbilettae)
Barbinal
Barbipenyl
Barbiphen
Barbiphenyl
Barbipil
Barbita
Barbivis
Barbonal
Barbophen
Bardorm
Bartol
BAS 00226811
Bialminal
BIDD:PXR0061
Blu-phen
Blu-Phen
C07434
Cabronal
Calmetten
Calminal
Cardenal
CCRIS 502
Chardonna-2
CHEBI:8069
CHEMBL40
Chinoin
CID4763
Codibarbita
component of Antrocol
component of Bronkotabs
component of Hecadrol
component of Primatene P
component of Slowten
component of Tedral
component of Valpin 50-PB
Coronaletta
Cratecil
d ezibarbitur
D00506
Damoral
DB01174
DEA No. 2285
Dezibarbitur
DivK1c_000987
Donphen
Dormina
Dormiral
Dormital
Doscalun
Duneryl
EINECS 200-007-0
Elixir of phenobarbital
Ensobarb
Ensodorm
Epanal
Epidorm
Epilol
Episedal
Epsylone
Eskabarb
Etilfen
Euneryl
fen osed
Fenbital
Fenemal
Fenobarbital
Fenobarbital [INN-Spanish]
Fenobarbitale
Fenobarbitale [DCIT]
Fenosed
Fenylettae
Gardenal
Gardepanyl
Glysoletten
Gustase-Plus
Haplopan
Haplos
Helional
Hennoletten
Henotal
HMS503E15
HSDB 3157
Hypnaletten
Hypnette
Hypnogen
Hypnolone
Hypnoltol
Hypno-Tablinetten
Hysteps
I06-0652
IDI1_000987
InChI=1/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17
KBio1_000987
le phebar
Lefebar
Leonal
Lephebar
Lepinal
|
Lepinaletten
Levsin PB Drops and Tablets
Linasen
Liquital
Lixophen
LS-135
Lubergal
Lubrokal
Lumen
Lumesettes
Lumesyn
Luminal
Luminal (TN)
Lumofridetten
Luphenil
Luramin
MLS001240232
Molinal
MolPort-001-783-066
MolPort-003-959-166
Monosodium salt phenobarbital
NCGC00159493-02
NCGC00159493-03
Neurobarb
NINDS_000987
Nirvonal
Noptil
Nova-Pheno
NSC 128143
NSC128143
NSC9848
Nunol
Oprea1_384816
P1636_SIGMA
Pamine PB
Parkotal
Pharmetten
Phazyme-PB
Phenaemal
Phen-Bar
Phenemal
Phenemalum
Phenobal
Phenobarb
phenobarbital
Phenobarbital
Phenobarbital (JP15/USP/INN)
phenobarbital (PB)
Phenobarbital [USAN:INN:JAN]
Phenobarbital sodium
Phenobarbital, monosodium salt
Phenobarbital, Monosodium Salt
Phenobarbitalum
Phenobarbitalum [INN]
Phenobarbitalum [INN-Latin]
Phenobarbitate
Phenobarbitic acid
Phenobarbitol
phenobarbitone
Phenobarbitone
Phenobarbitonum
Phenobarbituric acid
Phenobarbituric Acid
Phenobarbyl
Phenoluric
Phenolurio
Phenomet
Phenonyl
Phenoturic
Phenylaethylbarbitursaeure
Phenyläthylbarbitursäure
Phenylbarbital
Phenylethyl barbituric acid
Phenylethylbarbitate
Phenylethylbarbitic acid
Phenylethylbarbiturate
Phenylethylbarbituric acid
Phenyl-ethyl-barbituric acid
Phenylethylbarbituric Acid
Phenylethylbarbitursaeure
Phenylethylbarbitursäure
Phenylethylmalonylurea
PHENYLETHYLMALONYLUREA
Phenyletten
phenylral
Phenyral
Phob
PHOB
Polcominal
Promptonal
PUBERTAL PHENOBARBITAL STUDY
Sedabar
seda-tabl inen
Seda-Tablinen
Sedicat
Sedizorin
Sedlyn
Sedofen
Sedonal
Sedonal (sedative)
Sedonettes
Sedophen
Sevenal
Sinoratox
SK-Phenobarbital
SMR000058986
Sodium, phenobarbital
Solfoton
Solfoton talpheno
Solfoton Talpheno
Solu-Barb
Sombutol
Somnolens
Somnoletten
Somnosan
Somonal
Spasepilin
Starifen
Starilettae
Stental
stental exte ntabs
Stental Extentabs
Talpheno
Teolaxin
Teoloxin
Thenobarbital
Theoloxin
theominal
Triabarb
Tridezibarbitur
Triphenatol
UNII-YQE403BP4D
Valprin 50-PB
Versomnal
WLN: T6VMVMV FHJ F2 FR
Zadoletten
Zadonal
|
|
13 |
|
Ketamine |
Approved, Vet_approved |
Phase 4 |
|
6740-88-1 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
100477-72-3
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chloro-Phenyl)-2-methylamino-cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-Chlorophenyl)cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
Calipsol
Calypsol
Cetamina
Cetamina [INN-Spanish]
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
DivK1c_000217
|
dl-Ketamine
DL-ketamine
DL-Ketamine
EINECS 229-804-1
Esketamine
Green
IDI1_000217
Kalipsol
KBio1_000217
Ketaject
Ketalar
Ketalar base
Ketamina
ketamine
Ketamine
Kétamine
Ketamine (INN)
Ketamine [INN:BAN]
Ketamine base
Ketamine Base
Ketamine HCL
KETAMINE HCL
Ketamine hydrochloride
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketaset
Ketoject
Ketolar
l-Ketamine
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
|
|
14 |
|
Diazepam |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
439-14-5 |
3016 |
Synonyms:
11100-37-1
1-Methyl-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
439-14-5
5-24-04-00300 (Beilstein Handbook Reference)
53320-84-6
7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
7-chloro-1,3-dihydro-1-Methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
7-Chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepine
7-Chloro-1-methyl-5-3H-1,4-benzodiazepin-2(1H)-one
7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Chloro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
7-Chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2(1H)-one
7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
A3662/0155188
AC-10561
AC1L1EZE
AKOS003367969
Alboral
Aliseum
Alupram
Amiprol
An-Ding
Ansilive
Ansiolin
Ansiolisina
Antenex
Anxicalm
Anxionil
Apaurin
Apo-diazepam
Apo-Diazepam
Apozepam
Armonil
Arzepam
Assival
Atensine
Atilen
Azedipamin
Baogin
Bensedin
Benzopin
Best [Pharaceutical]
Betapam
Bialzepam
BIDD:GT0105
BIDD:PXR0158
BRD-K16508793-001-01-8
Britazepam
BRN 0754371
BSPBio_003279
C06948
Calmaven
Calmocitene
Calmociteno
Calmod
Calmpose
Caudel
CB 4261
CCRIS 6009
Centrazepam
Cercine
Ceregulart
CHEBI:49575
CHEMBL12
Chuansuan
CID3016
Condition
CPD000058398
D00293
D003975
D0899_SIGMA
D9900_FLUKA
D9900_SIGMA
DAP
DB00829
DB07699
DEA No. 2765
Desconet
Desloneg
Diacepan
Diaceplex
Dialag
Dialar
Diapam
Diapax
Diapine
Diaquel
Diastat
Diastat (TN)
Diastat Acudial
Diatran
Diazapam
Diazem
Diazemuls
Diazemulus
diazepam
Diazepam
Diazepam (JP15/USP/INN)
Diazepam [USAN:INN:BAN:JAN]
Diazepam Dak
Diazepam Desitin
Diazepam Elmu
Diazepam Fabra
Diazepam Intensol
Diazepam Nordic
Diazepam Rectubes
Diazepam solution
Diazepam Stada
Diazepam-Eurogenerics
Diazepam-Lipuro
Diazepam-ratiopharm
Diazepamu
Diazepamu [Polish]
Diazepamum
Diazepamum [INN-Latin]
Diazepan
Diazepan leo
Diazepin
Diazetard
Dienpax
Dipam
Dipaz
Dipezona
Disopam
DivK1c_000967
Dizac
Domalium
Doval
D-Pam
Drenian
Ducene
Duksen
Dupin
Duxen
DZP
EINECS 207-122-5
Elcion CR
e-Pam
E-Pam
Eridan
Euphorin P
Eurosan
Evacalm
Faustal
Faustan
Faustan,
Freudal
Frustan
Gewacalm
Gihitan
Gradual
Gubex
HMS2051N04
HMS503A15
HSDB 3057
I06-0194
Iazepam
|
IDI1_000967
Jinpanfan
Kabivitrum
KBio1_000967
KBio3_002780
KBioGR_001012
Kiatrium
Kratium
Kratium 2
LA 111
LA III
LA-111
La-Iii
Lamra
Lembrol
Levium
Liberetas
Lizan
Lovium
LS-122
Mandro
Mandrozep
Mandro-Zep
Medipam
Mentalium
Metamidol
Methyl diazepinone
Methyldiazepinone
Methyldiazepinone (pharmaceutical)
Methyldiazepinone, pharmaceutical
Metil Gobanal
MLS000759402
MolPort-001-729-114
Morosan
NCGC00178168-01
nchembio.307-comp2
nchembio747-comp27
Nellium
Nerozen
Nervium
neurolytr il
Neurolytril
NINDS_000967
Nivalen
Nixtensyn
Noan
Notense
Novazam
Novodipam
Novo-Dipam
NSC 169897
NSC169897
NSC77518
NSC-77518
Oprea1_126223
Ortopsique
Paceum
Pacitran
Paralium
Paranten
Parzam
Paxate
Paxel
Paxum
Placidox 10
Placidox 2
Placidox 5
Plidan
Pms-Diazepam
Pomin
Pro-Pam
ProPAM
Prozepam
Psychopax
Q-pam
Q-Pam
Q-Pam Relanium
Quetinil
Quiatril
Quievita
Radizepam
Relaminal
Relanium
Reliver
Renborin
Ro 5-2805
Ro 5-2807
Ruhsitus
S.A. R.L
S.a. r.l.
SAM001246536
Saromet
Sedapam
Sedipam
Seduksen
Seduxen
Serenack
Serenamin
Serenzin
Servizepam
Setonil
Sibazon
Sibazone
Sico Relax
Simasedan
Sipam
SMR000058398
Solis
Sonacon
Spectrum3_001780
Spectrum4_000576
Spectrum5_001890
Stesolid
Stesolin
STK735517
Tensium
Tensopam
T-quil
Tranimul
Trankinon
Tranqdyn
Tranquase
Tranquirit
Tranquo-puren
Tranquo-Puren
Tranquo-tablinen
Tranquo-Tablinen
Trazepam
Umbrium
UNII-Q3JTX2Q7TU
Unisedil
Usempax ap
Usempax Ap
Valaxona
Valeo
Valiquid
Valitran
Valium
Valium (TN)
Valium R
Valrelease
Valuzepam
Vanconin
Vatran
Vazen
Vazepam
Velium
Vival
Vivol
Winii
WLN: T67 GNV JN IHJ CG G1 KR
Wy 3467
WY-3467
Zepaxid
Zetran
ZINC00006427
Zipan
|
|
15 |
|
Olanzapine |
Approved, Investigational |
Phase 4 |
|
132539-06-1 |
4585 |
Synonyms:
132539-06-1
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC1L1IHS
AC-665
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
Lanzac
Lilly brand of olanzapine
LS-152313
LY 170053
LY-170052
|
LY-170053
Midax
MLS000759457
MLS001165781
MLS001195646
MLS001424057
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
olanzapina
Olanzapina
olanzapine
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
olanzapinum
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa intramuscular
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa zydis
Zyprexa Zydis
|
|
16 |
|
Dopamine |
Approved |
Phase 4 |
|
51-61-6, 62-31-7 |
681 |
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
17 |
|
Haloperidol |
Approved |
Phase 4 |
|
52-86-8 |
3559 |
Synonyms:
1-(3-p-fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine
1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine
4-(4-(para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-fluoro-4-(4-(P-Chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
4'-fluoro-4-(4-Hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
5-21-02-00377 (Beilstein Handbook Reference)
52-86-8
AB00052008
AC-19691
AC1L1G7K
AC1Q77Z0
AKOS000280660
Aldo
ALDO
Aloperidin
Aloperidol
Aloperidolo
Aloperidolo [DCIT]
Aloperidolo [Italian]
Aloperidon
Apo-Haloperidol
BIDD:GT0128
Bio-0705
Biomol-NT_000035
Bioperidolo
BPBio1_000144
BPBio1_001231
BRD-K67783091-001-04-8
BRD-K67783091-001-05-5
BRN 0331267
Brotopon
BSPBio_000130
BSPBio_002096
C01814
C21H23ClFNO2
CAS-52-86-8
CCRIS 1630
CHEBI:5613
CHEMBL54
CID3559
cMAP_000037
D00136
D006220
DB00502
DivK1c_000654
Dozic
Dozix
Einalon S
EINECS 200-155-6
EU-0100583
Eukystol
Fortunan
g-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone
Galoperidol
gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone
H 1512
H0912
H1512_SIGMA
Haldol
Haldol Decanoate
Haldol La
Haldol Solutab
Halidol
Halojust
Halol
Halopal
Haloperido
haloperidol
Haloperidol
Haloperidol (JP15/USP)
Haloperidol (JP15/USP/INN)
Haloperidol [USAN:INN:BAN:JAN]
Haloperidol Decanoate
Haloperidol Intensol
Haloperidol Lactate
Haloperidolum
Haloperidolum [INN-Latin]
Halopidol
Halopoidol
Halosten
HMS1568G12
HMS1920D03
HMS2089M15
HMS2091J09
|
HMS502A16
HSDB 3093
I14-13404
I14-14165
IDI1_000654
KBio1_000654
KBio2_001341
KBio2_002390
KBio2_003909
KBio2_004958
KBio2_006477
KBio2_007526
KBio3_001316
KBio3_002869
KBioGR_000980
KBioGR_002390
KBioSS_001341
KBioSS_002395
Keselan
L000288
Lealgin compositum
Lealgin Compositum
Linton
Lopac0_000583
Lopac-H-1512
LS-48311
McN-JR-1625
Mixidol
MLS000028450
MLS001146904
MolPort-000-883-311
NCGC00015500-01
NCGC00015500-02
NCGC00015500-06
NCGC00015500-14
NCGC00016234-01
NCGC00023875-02
NCGC00023875-04
NCGC00023875-05
NCGC00023875-06
NCGC00023875-07
NCGC00023875-08
NCGC00023875-09
NINDS_000654
Novo-Peridol
NSC 170973
NSC 615296
NSC170973
NSC615296
Oprea1_509923
Pekuces
Peluces
Peridol
Pernox
Pms Haloperidol
Prestwick_250
Prestwick0_000115
Prestwick1_000115
Prestwick2_000115
Prestwick3_000115
Probes1_000255
Probes2_000296
QTL1_000042
R 1625
R-1625
S1920_Selleck
Serenace
Serenase
Serenelfi
Sernas
Sernel
Sigaperidol
SMR000058303
SPBio_001236
SPBio_002069
Spectrum_000861
SPECTRUM1500325
Spectrum2_001268
Spectrum3_000448
Spectrum4_000570
Spectrum5_000788
Tocris-0931
Ulcolind
Uliolind
UNII-J6292F8L3D
Vesalium
WLN: T6NTJ A3VR DF& DQ DR DG
γ-(4-(p-chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
γ-(4-(P-chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone
|
|
18 |
|
Carbamazepine |
Approved, Investigational |
Phase 4 |
|
298-46-4 |
2554 |
Synonyms:
298-46-4
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz(b,F)azepine
5-carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
benzo[b][1]benzazepine-11-carboxamide
BIDD:GT0479
BIM-0050280.0001
Bio-0751
Bipotrol
Biston
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
carbamazepine
Carbamazepine
Carbamazépine
Carbamazepine (JP15/USP/INN)
carbamazepine (Tegretol)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepine acetate
Carbamazepine anhydrous
Carbamazepine dihydrate
Carbamazepine hydrochloride
Carbamazepine L-tartrate (4:1)
Carbamazepine phosphate
Carbamazepine sulfate (2:1)
CARBAMAZEPINE, U.S.P.
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
ChemDiv1_018966
CID2554
CPD001227191
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
Equetro
|
Equetro (TN)
EU-0100292
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
Karbamazepin
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Lexin
Lopac0_000292
Lopac-C-4024
LS-60362
MLS000069652
MLS001055475
MLS001074172
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
nchem.859-comp7
Neurotol
Neurotop retard
NINDS_000388
Novo-Carbamaz
NSC 169864
NSC169864
Nu-Carbamazepine
Oprea1_790775
Prestwick_104
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
S1693_Selleck
SAM002264603
Sirtal
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
Spectrum_000096
SPECTRUM1500159
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Stazepin
Stazepine
STK177357
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
|
|
19 |
|
Valproic acid |
Approved, Investigational |
Phase 4 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 PP (base)
2 Propylpentanoic acid
2-N-Propyl-N-valerate
2-n-propyl-n-valeric acid
2-n-Propyl-n-valeric acid
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-propyl-pentanoic acid
2-Propylpentanoic acid
2-Propylpentanoic Acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-propylvaleric acid
2-Propylvaleric acid
2-Propylvaleric Acid
4-Heptanecarboxylate
4-heptanecarboxylic acid
4-Heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
Abbott 44090
AC1L1F7T
AC1Q2ULA
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acide valproique [INN-French]
acido Valproico
Acido valproico
ácido valproico
Acido valproico [INN-Spanish]
acidum valproicum
Acidum valproicum
Acidum valproicum [INN-Latin]
AI3-10500
Alti-valproic
Alti-Valproic
apo-Divalproex
apo-Valproic
apo-Valproic syrup
Avugane
Baceca
BIDD:GT0858
BRN 1750447
C07185
Calcium valproate
Calcium, valproate
CHEBI:39867
CHEMBL109
CID3121
Convulex
Convulsofin
CPD000499581
D00399
DB00313
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetate
di-n-propylacetic acid
Di-n-propylacetic acid
Di-N-propylacetic acid
Di-n-propylessigsaeure
Di-N-propylessigsaeure
Di-n-propylessigsaure
Di-N-propylessigsaure
Di-n-propylessigsäure
Di-n-propylessigsaure [German]
Dipropyl acetate
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DivK1c_000273
DOM-divalproex
Dom-valproate
Dom-Valproic
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
EINECS 202-777-3
Epiject i.v.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
|
KBio2_004845
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
Magnesium valproate
Med valproic
Med Valproic
MLS001076682
MLS001335927
MLS001335928
MLS002415770
MolPort-001-791-895
Mylproin
Myproate
Myproic acid
Myproic Acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
nchembio.79-comp4
nchembio815-comp21
n-Dipropylacetic acid
N-Dipropylacetic acid
n-DPA
N-DPA
NINDS_000273
novo-Divalproex
novo-Valproic
Novo-Valproic
novo-Valproic - ecc
novo-Valproic soft gel cap
NSC 93819
NSC93819
Nu-valproic
Nu-Valproic
P0823
P6273_SIGMA
PEAC
Penta-valproic
Penta-Valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic Acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
ratio-Valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
Sandoz valproic
Savicol
SBB065764
Semisodium valproate
Semisodium Valproate
SMR000499581
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
SPBio_000912
Spectrum_000521
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Sprinkle
Stavzor
UNII-614OI1Z5WI
Valcote
Valparin
valproate
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
valproic acid
Valproic acid
VALPROIC ACID
Valproic acid (USP)
Valproic acid [USAN:INN:BAN]
Valproic acid usp
Valproic acid USP
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproic Acid, Sodium Salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
WLN: QVY3 & 3
|
|
20 |
|
Gabapentin |
Approved, Investigational |
Phase 4 |
|
60142-96-3 |
3446 |
Synonyms:
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
1-(Aminomethyl)cyclohexaneacetate
1-(Aminomethyl)cyclohexaneacetic acid
1-(Aminomethyl)-cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
Aclonium
AKOS000280865
apo-Gabapentin
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
Convalis
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G0318
G-154
G154_SIGMA
Gabapen
gabapentin
Gabapentin
Gabapentin (JAN/USAN/INN)
gabapentin (Neurontin)
Gabapentin [USAN:INN:BAN]
Gabapentin GR
Gabapentin hexal
Gabapentin Hexal
Gabapentin stada
Gabapentin Stada
gabapentina
Gabapentina
Gabapentine
Gabapentine [INN-French]
gabapentinium
Gabapentino
|
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentin-ratiopharm
Gabapentinum
Gabapentinum [INN-Latin]
Gabapetin
GBN
Go 3450
GOE 2450
Goe-3450
Hexal brand of gabapentin
HMS1570N03
HMS2089J03
HSDB 7364
I06-0677
L000733
Lopac0_000582
Lopac-G-154
LS-7194
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
Neurontin
Neurontin (TN)
novo-Gabapentin
Novo-Gabapentin
novo-Gabapentine
Novopharm brand of gabapentin
NSC742194
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
PMS-Gabapentin
Prestwick_151
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
ratiopharm brand of gabapentin
S2133_Selleck
Serada
SMR000058311
SPBio_002822
Stadapharm brand of gabapentin
STK598009
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
|
|
21 |
|
Pregabalin |
Approved, Investigational |
Phase 4 |
|
148553-50-8 |
5486971 |
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(R-)-3-Isobutyl gaba
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S)-3-Isobutyl GABA
(S+)-3-isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3 Isobutyl gaba
3-(Aminomethyl)-5-methylhexanoic acid
3-isobutyl GABA
3-Isobutyl gaba
3-Isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
|
CI-1008
CID5486971
D02716
DB00230
FT-0080911
GABA, 3-isobutyl
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregabalina
Pregablin
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
|
|
22 |
|
Phenytoin |
Approved, Vet_approved |
Phase 4 |
|
57-41-0 |
1775 |
Synonyms:
125-59-7
2,4-Imidazolidinedione, 5,5-diphenyl- (9CI)
2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one
5,5-Diphenyl-2,4-imidazolidinedione
5,5-diphenylhydantoin
5,5-Diphenylhydantoin
5,5-DIPHENYLHYDANTOIN
5,5-Diphenylhydantoin (IUPAC)
5,5-Diphenylhydantoin (phenytoin)
5,5-Diphenylimidazolidin-2,4-dione
5,5-diphenylimidazolidine-2,4-dione
5,5-Diphenylimidazolidine-2,4-dione
5,5-Diphenyl-imidazolidine-2,4-dione
5,5-diphenyltetrahydro-1H-2,4-imidazoledione
5,5-diphenyltetrahydro-1H-2,4-Imidazoledione
5,5-Diphenyltetrahydro-1H-2,4-imidazoledione
5,5-Dwufenylohydantoina
5,5-Dwufenylohydantoina [Polish]
57-41-0
630-93-3
AC1L1C7L
AC1Q6G55
AC1Q6G56
AC-376
AI3-52498
AKOS000416887
AKOS003245432
Aleviatin
Antisacer
Auranile
BAS 00281572
BIDD:GT0625
BIDD:PXR0090
Bio-0370
BRD-K55930204-001-02-7
BSPBio_001437
C07443
Causoin
CCRIS 515
CHEBI:8107
CHEMBL16
CID1775
Citrullamon
Citrulliamon
CL12003
Comital
Comitoina
component of Mebroin
Convul
D 4007
D00512
D0894
D4007_SIGMA
Danten
Dantinal
Dantoinal
Dantoinal klinos
Dantoine
DB00252
Denyl
Didan TDC 250
Didan-tdc-250
Difenilhidantoina
Difenilhidantoina [Spanish]
Difenin
Difetoin
Difhydan
Dihycon
Dihydan
Di-Hydan
Dihydan toin
Dihydantoin
Dilabid
Di-Lan
Di-Lan (VAN)
Dilantin
DILANTIN
Dilantin (TN)
Dilantin acid
Dilantin-125
DILANTIN-30
Dilantine
Dillantin
Dintoin
Dintoina
Diphantoin
Diphedal
Diphedan
Diphenat
Diphenin
Diphenine
Diphentoin
Diphentyn
Diphenylan
Diphenylan sodium
Diphenylan Sodium
Diphenylhydantoin
Diphenylhydantoin (VAN)
Diphenylhydantoinate, sodium
Diphenylhydantoine
Diphenylhydantoine [French]
Diphenylhydatanoin
Di-Phetine
Ditoinate
DivK1c_000507
DPH
DPH (VAN)
EINECS 200-328-6
Ekko
Ekko capsules
elepsi ndon
Elepsindon
Enkelfel
Epamin
Epanutin
Epasmir "5"
epasmir ''5''
Epasmir 5
Epdantoin Simple
Epdantoine simple
Epelin
Epifenyl
Epihydan
Epilan
Epilan D
Epilan-D
Epilantin
Epinat
Epised
Eptal
Eptoin
EU-0100378
Extended Phenytoin Sodium
fen toin
Fenantoin
Fenantoin Mn Pharma
Fenidantoin "s"
fenidantoin ''s''
Fenidantoin s
Fenitoin
Fenitoina
Fenitoina [INN-Spanish]
Fentoin
Fenylepsin
Fenytoin Dak
Fenytoine
|
Gerot-epilan-D
Hidan
Hidantal
Hidantilo
Hidantina
Hidantina senosian
Hidantina vitoria
Hidantomin
Hindatal
HMS1412J16
HMS1694O05
HMS1791H19
HMS1989H19
HMS2089E11
Hydantal
Hydantin
Hydantoin
Hydantoin, 5,5-diphenyl- (8CI)
Hydantoinal
Hydantol
I14-6452
ictalis simp le
Ictalis simple
Idantoil
Idantoin
IDI1_000507
IDI1_008433
IFLab1_000214
InChI=1/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19
Iphenylhydantoin
KBio1_000507
KBio2_001585
KBio2_004153
KBio2_006721
KBio3_001780
KBioGR_001387
KBioSS_001585
Kessodanten
Labopal
Lehydan
Lepitoin
Lepsin
Lopac0_000329
Lopac0_000378
Lopac-D-4007
LS-34
Mesantoin
Minetoin
MLS000069789
MLS001074087
MLS002454401
MolPort-001-785-683
MolPort-002-365-712
MolPort-004-876-351
NCGC00015342-01
NCGC00015342-02
NCGC00015342-04
NCGC00021139-01
NCGC00091492-01
NCGC00091492-02
NCGC00091492-03
NCGC00091492-04
NCGC00091492-05
NCGC00093810-01
NCGC00093810-02
NCI-C55765
Neos-Hidantoina
Neosidantoina
NINDS_000507
Novantoina
Novophenytoin
NSC 8722
NSC8722
Om hidantoina simple
Om-Hydantoine
Oprea1_373280
Oxylan
Park davis brand OF phenytoin
Pfizer brand OF phenytoin
Phanantin
Phanatine
phenat ine
Phenatine
Phenatoine
Phenhydan
Phenhydanin
Phenitoin
Phentoin
Phentytoin
PHENTYTOIN
PHENYTEK
Phenytex
phenytoin
Phenytoin
PHENYTOIN (5,5-DIPHENYLHYDANTOIN)
Phenytoin (JP15/USP/INN)
phenytoin (PHN)
Phenytoin [USAN:INN:BAN:JAN]
Phenytoin AWD
Phenytoin pfizer brand
Phenytoin phizer brand
Phenytoin sodium
Phenytoin Sodium
PHENYTOIN SODIUM, EXTENDED
Phenytoine
Phenytoine [INN-French]
Phenytoin-Gerot
Phenytoinum
Phenytoinum [INN-Latin]
Phizer brand OF phenytoin
Prompt Phenytoin Sodium
Ritmenal
Saceril
Sanepil
Silantin
Sinergina
SMR000059026
Sodanthon
Sodantoin
Sodanton
Sodium diphenylhydantoinate
Sodium Diphenylhydantoinate
Solantin
Solantoin
Solantyl
SPBio_001281
Spectrum_001105
Spectrum2_001281
Spectrum3_000890
Spectrum4_000984
Spectrum5_001369
STK058029
STK182871
Sylantoic
taco sal
Tacosal
Thilophenyl
TOIN
Toin unicelles
UNII-6158TKW0C5
WLN: T5MVMV EHJ ER& ER
Zentronal
Zentropil
ZINC02510358
ZINC18140189
|
|
23 |
|
Zonisamide |
Approved, Investigational |
Phase 4 |
|
68291-97-4 |
5734 |
Synonyms:
1-(1,2-benzisoxazol-3-yl)methanesulfonamide
1-(1,2-Benzoxazol-3-Yl)methanesulfonamide
1,2-Benzisoxazole-3-methanesulfonamide
1,2-Benzisoxazole-3-methanesulphonamide
1,2-benzoxazol-3-ylmethanesulfonamide
3-(Sulfamoylmethyl)-1,2-benzisoxazole
3-(Sulphamoylmethyl)-1,2-benzisoxazole
3-sulfamoylmethyl-1,2-benzisoxazole
3-Sulfamoylmethyl-1,2-benzisoxazole
68291-97-4
AC-1413
AC1L1L0Q
AC1Q55GQ
AD 810
AD-810
AD-810N
AKOS001312269
benzo[D]Isoxazol-3-yl-methanesulfonamide
Benzo[d]isoxazol-3-yl-methanesulfonamide
benzo[D]Isoxazol-3-yl-methanesulphonamide
BIDD:GT0708
BIDD:PXR0183
Bio-0532
BRD-K48300629-001-03-8
BRN 1077076
C022189
C07504
C8H8N2O3S
CHEBI:10127
CHEMBL750
CI 912
CI-912
CID5734
CPD000596519
D00538
DB00909
E-2090
Elan brand of zonisamide
Elan brand OF zonisamide
|
Exceglan
Excegram
Excegran
Excegran (TN)
FT-0082702
HMS2089O07
HSDB 7293
I06-0495
LS-33637
MLS001195632
MLS001306491
MolPort-002-507-855
NCGC00159319-02
NCGC00159319-03
PD 110843
PD-110843
S1445_Selleck
SAM002548957
SMR000596519
SPR_2
STK711131
Tremode
Trerief
UNII-459384H98V
ZINC00004321
Zonegran
Zonegran, Zonisamide
Zonisamida
Zonisamida [Spanish]
zonisamide
Zonisamide
Zonisamide (JAN/USAN/INN)
Zonisamide (ZNS)
Zonisamide [USAN:BAN:INN:JAN]
zonisamide monosodium
Zonisamide monosodium
Zonisamidum
Zonisamidum [Latin]
|
|
24 |
|
Probenecid |
Approved, Investigational |
Phase 4 |
|
57-66-9 |
4911 |
Synonyms:
4-((dipropylamino)Sulfonyl)benzoate
4-((dipropylamino)Sulfonyl)benzoic acid
4-((Dipropylamino)sulfonyl)benzoic acid
4-((dipropylamino)Sulphonyl)benzoate
4-((dipropylamino)Sulphonyl)benzoic acid
4-(Di-n-propylsulfamoyl)benzoesaeure
4-(Di-N-propylsulfamoyl)benzoesaeure
4-(Di-n-propylsulfamoyl)benzoesäure
4-(Di-N-propylsulphamoyl)benzoesaeure
4-(Dipropylsulfamoyl)benzoic acid
4-(N,N-Dipropylsulfamoyl)benzoesaeure
4-(N,N-Dipropylsulfamoyl)benzoesäure
4-(N,N-Dipropylsulphamoyl)benzoesaeure
4-[(dipropylamino)sulfonyl]benzoic acid
57-66-9
AB00052080
AC1L1J86
AC1Q2XQM
AC1Q2XQN
AC-2023
AI3-50078
AKOS000165123
Apurina
Bencid
Benecid
Benemid
Benemid (TN)
Benemide
Benuryl
BIDD:GT0626
BIDD:PXR0092
Biokanol brand OF probenecid
Biokanol Brand of Probenecid
BPBio1_000643
BRD-K95237249-001-05-9
BRN 2815775
BSPBio_000583
BSPBio_002227
C07372
C13H19NO4S
CAS-57-66-9
CCRIS 3643
CHEBI:177474
CHEMBL897
CID4911
Colbenemid
Col-BENEMID
ColBenemid (co mponent of)
ColBenemid (component of)
Col-Probenecid
CPD000058280
D00475
D011339
DB01032
DivK1c_000056
EINECS 200-344-3
HMS1569N05
HMS1920J22
HMS2092C03
HMS500C18
HSDB 3387
I01-1905
ICN brand OF probenecid
ICN Brand of Probenecid
IDI1_000056
IDIS brand OF probenecid
IDIS Brand of Probenecid
KBio1_000056
KBio2_001314
KBio2_003882
KBio2_006450
KBio3_001727
KBioGR_000971
KBioSS_001314
LS-33
Major brand OF probenecid
Major Brand of Probenecid
Martec brand OF probenecid
Martec Brand of Probenecid
Merck brand OF probenecid
Merck Brand of Probenecid
MLS000028496
MLS001076472
MolPort-000-145-935
NCGC00016251-01
NCGC00016251-02
NCGC00023829-03
NCGC00023829-04
|
NCGC00023829-05
NCGC00023829-06
NCI-C56097
NINDS_000056
NSC 18786
NSC18786
Ophthalmic brand OF probenecid
Ophthalmic Brand of Probenecid
Oprea1_416955
P-(Dipropylsulfamoyl)benzoate
p-(Dipropylsulfamoyl)benzoic acid
P-(Dipropylsulfamoyl)benzoic acid
p-(Dipropylsulfamyl)benzoic acid
P-(Dipropylsulphamoyl)benzoate
P-(Dipropylsulphamoyl)benzoic acid
p-[Dipropylsulfamoyl]benzoic acid
P8761_SIGMA
Panuric
Parabenem
Parmed brand OF probenecid
Parmed Brand of Probenecid
Polycillin-BRB
Polycillin-PRB
Polycillin-PRB (component of)
Prestwick_809
Prestwick0_000542
Prestwick1_000542
Prestwick2_000542
Prestwick3_000542
Probalan
Probampacin
Probecid
Proben
Proben-C
probenecid
Probenecid
Probenecid (JP15/USP/INN)
Probenecid [INN:BAN:JAN]
Probenecid acid
Probenecid Acid
Probenecid major brand
Probenecid Major Brand
Probenecid martec brand
Probenecid Martec Brand
Probenecid parmed brand
Probenecid Parmed Brand
Probenecid weimer
Probenecid Weimer
Probenecid zenith brand
Probenecid Zenith Brand
Probenecida
Probenecida [INN-Spanish]
Probenecide
Probenecide [INN-French]
Probenecidum
Probenecidum [INN-Latin]
Probenemid
probenicid
Probenicid
Probenid
Probexin
pro-Cid
Pro-Cid
Prolongine
Robenecid
SAM002554923
SBB028597
SMR000058280
SPBio_001327
SPBio_002504
Spectrum_000834
SPECTRUM1500502
Spectrum2_001294
Spectrum3_000554
Spectrum4_000486
Spectrum5_001419
Sulprin
Synergid R
Tubophan
UNII-PO572Z7917
Uricosid
Urocid
Valdecasas brand OF probenecid
Valdecasas Brand of Probenecid
WLN: QVR DSWN3&3
Zenith brand OF probenecid
Zenith Brand of Probenecid
|
|
25 |
|
Vigabatrin |
Approved |
Phase 4 |
|
68506-86-5, 60643-86-9 |
5665 |
Synonyms:
( inverted question mark)-gamma-Vinyl GABA
(?)-gamma-Vinyl GABA
(R,S)-4-Amino-5-hexenoic acid
.gamma.-Vinyl-.gamma.-aminobutyric acid
.gamma.-Vinyl-GABA
4-amino-5-Hexenoate
4-amino-5-Hexenoic acid
4-Amino-5-hexenoic acid
4-aminohex-5-enoic acid
4-Aminohexenoic acid
60643-86-9
74046-07-4
AB00053309
AC1L1KUZ
Acid, gamma-vinyl-gamma-aminobutyric
Acid, gamma-Vinyl-gamma-Aminobutyric
Aventis brand OF vigabatrin
Aventis Brand of Vigabatrin
Biomol-NT_000247
BPBio1_000465
BPBio1_000925
BSPBio_000421
BSPBio_003469
C07500
C6H11NO2
CHEBI:241484
CHEMBL89598
CID5665
CPP-109
D00535
D020888
DB01080
DivK1c_006760
EU-0101277
gamma Vinyl gaba
gamma Vinyl GABA
Gamma vinyl GABA
gamma Vinyl gamma aminobutyric acid
gamma Vinyl gamma Aminobutyric Acid
gamma-Vinyl gaba
gamma-Vinyl GABA
gamma-Vinyl-gaba
gamma-Vinyl-GABA
gamma-Vinyl-gamma-aminobutyrate
gamma-Vinyl-gamma-aminobutyric acid
gamma-Vinyl-gamma-Aminobutyric Acid
GVG
g-Vinyl gaba
g-Vinyl-g-aminobutyrate
g-Vinyl-g-aminobutyric acid
Hexenoic acid, 4-amino
HMS1569F03
HMS2094M21
Hoechst brand OF vigabatrin
Hoechst Brand of Vigabatrin
KBio1_001704
KBio2_000848
KBio2_003416
|
KBio2_005984
KBio3_002973
KBioSS_000848
Lopac0_001277
LS-75569
M071754
MDL 71,754
MDL 71754
MDL-71754
MolPort-003-666-796
NCGC00016087-03
NCGC00016087-08
NCGC00024802-02
NCGC00024802-03
NCGC00024802-04
NCGC00024802-05
NCGC00024802-06
Prestwick_837
Prestwick0_000501
Prestwick1_000501
Prestwick2_000501
Prestwick3_000501
RMI 71754
RMI-71754
RMI-71890
Sabril
Sabril (TN)
Sabrilex
SPBio_002342
SpecPlus_000664
Spectrum_000368
SPECTRUM1502036
Spectrum3_001825
V 8261
V8261_SIGMA
vigabatrin
Vigabatrin
Vigabatrin (JAN/USAN/INN)
Vigabatrin [USAN:BAN:INN]
Vigabatrin [USAN:INN:BAN]
Vigabatrin aventis brand
Vigabatrin Aventis Brand
Vigabatrin hoechst brand
Vigabatrin Hoechst Brand
Vigabatrin yamanouchi brand
Vigabatrin Yamanouchi Brand
Vigabatrina
Vigabatrina [Spanish]
Vigabatrine
Vigabatrine [French]
Vigabatrinum
Vigabatrinum [Latin]
Vinyl gamma-aminobutyric acid
Yamanouchi brand OF vigabatrin
Yamanouchi Brand of Vigabatrin
γ-vinyl gaba
γ-vinyl-γ-aminobutyrate
γ-vinyl-γ-aminobutyric acid
|
|
26 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-33-8 |
2771 |
Synonyms:
[3H]Citalopram
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
Bonitrile
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
C07572
C20H21FN2O
Celapram
Celexa
Celius
CHEBI:3723
CHEMBL549
Ciazil
CID2771
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
citalopram
Citalopram
Citalopram (USP/INN)
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopram Hydrobromide
Citalopramum
Citalopramum [INN-Latin]
|
Citol
Citopam
Citox
Citrol
CPD000465669
Cytalopram
D07704
Dalsan
DB00215
EINECS 261-891-1
Elopram
Escitalopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
Lexapro
Lopac0_000258
LS-84327
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
Seropram
ST069372
STL058639
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
|
|
27 |
|
Vitamin D3 |
Approved, Nutraceutical |
Phase 4 |
|
67-97-0 |
5280795 6221 |
Synonyms:
()-Vitamin D3
(+)-vitamin D3
(+)-Vitamin D3
(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3Î’,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
47763_SUPELCO
57651-82-8
67-97-0
7-DEHYDROCHOLESTEROL
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
ACTIVATED
Activated 7-dehydrocholesterol
Arachitol
Bio-0845
bmse000507
BPBio1_000460
BSPBio_000418
BSPBio_002408
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
Calciol
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
cholecalciferol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferols
Cholecalciferolum
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
|
CID7067440
CID7251172
CID7251174
CID9821465
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Dihydrocholesterol
DivK1c_006276
Duphafral D3 1000
Ebivit
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
FeraCol
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC375571
NSC-375571
Oleovitamin D3
Prestwick_63
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Provitamine
Provitina
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SpecPlus_000180
Spectrum_001163
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
SR-05000001559
SR-05000001559-3
ST057172
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
Vi-de-3-hydrosol
Vigorsan
VITAMIN D
Vitamin D 3
vitamin d-3
Vitamin D3
Vitamin D-3
Vitamin D3 emulsifiable
VITAMIN D3 POWDER
VITAMIN_D3
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
δ-D
|
|
28 |
|
Calcifediol |
Approved, Nutraceutical |
Phase 4 |
|
19356-17-3 |
5283731 6433735 |
Synonyms:
(1R,3Z)-3-[(2E)-2-[(1R,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
(3S,5Z,7E)-9,10-secocholesta-5,7,10-triene-3,25-diol
(3S,5Z,7E)-9,10-Secocholesta-5,7,10-triene-3,25-diol
(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol
(5Z,7E)-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol
17938_FLUKA
17938_SIGMA
19356-17-3
25 Hydroxycholecalciferol
25 Hydroxycholecalciferol monohydrate
25 Hydroxyvitamin D 3
25 Hydroxyvitamin D3
25(OH)D3
25-(OH)Vitamin D3
25631-40-7
25-hydroxycholecalciferol
25-Hydroxycholecalciferol
25-Hydroxy-cholecalciferol
25-Hydroxycholecalciferol (Calcifediol)
25-Hydroxycholecalciferol monohydrate
25-Hydroxycholescalciferol
25-Hydroxyvitamin D
25-Hydroxyvitamin D 3
25-hydroxyvitamin D3
25-Hydroxyvitamin D3
25-Hydroxyvitamin D3 monohydrate
3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol
3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL
5,6-cis-25-Hydroxyvitamin D3
5,6-trans-25-Hydroxycholescalciferol
5,6-trans-9,10-Seco-5,7,10(19)-cholestatrien-3beta,25-diol
9,10-Secocholesta-5,7,10(19)-triene-3b,25-diol
9,10-Secocholesta-5,7,10(19)-triene-3beta,25-diol
AC1NR2WF
AC1O5GOQ
Anhydrous, calcifediol
Aventis brand OF calcifediol
B91135EC-8937-4D8B-A533-CCD82F33C1B0
BML2-E02
BSPBio_001411
|
C01561
Calcidiol
Calcifediol
Calcifédiol
Calcifediol anhydrous
Calcifediol aventis brand
Calcifediol faes brand
Calcifediol organon brand
Calcifediol, (3 alpha,5Z,7E)-isomer
Calcifediol, (3 beta,5E,7E)-isomer
Calcifediolum
Calcifediolum [INN-Latin]
Calcifidiol
Calderol
CHEBI:17933
CHEMBL1040
CHEMBL1222
CID5283731
CID6433735
DB00146
Dedrogyl
Delakmin
Didrogyl
EINECS 242-990-9
Faes brand OF calcifediol
H4014_SIGMA
Hidroferol
HMS1361G13
HMS1791G13
HMS1989G13
HMS2089L21
IDI1_033881
LMST03020246
MolPort-003-927-271
Monohydrate, 25-hydroxycholecalciferol
NCGC00161326-01
NCGC00161326-04
Organon brand OF calcifediol
Rayaldee
Ro 8-8892
S1469_Selleck
Spectrum5_001931
U-32070E
UNII-T0WXW8F54E
VDY
ZINC04474414
|
|
29 |
|
Vitamin D |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
1406-16-2 |
|
Synonyms:
|
Vitamin D, unspecified form
|
|
30 |
|
Vitamin E |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-02-9 |
14985 |
Synonyms:
(+)-alpha-Tocopherol
(+)-a-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-dihydro-2,5,7,8-Tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'r,8'r)-alpha-Tocopherol
(2R,4'r,8'r)-a-Tocopherol
(2R,4'r,8'r)-α-tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-trimethyltocol
5,7,8-Trimethyltocol
a-D-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
alpha-Tocopherol
Amino-Opti-E
Aquasol E
a-Tocopherol
D-alpha-Tocopherol
|
Daltose
D-a-Tocopherol
delta-alpha-Tocopherol
Denamone
d-α-tocopherol
D-α-tocopherol
E-200 I.U. Softgels
E-Complex-600
E-Ferol
Eprolin
E-Vitamin succinate
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-Tocopherol
RRR-alpha-Tocopheryl
Tocopherol
Vitamin e
Vitamin ea
Vitamin Plus E Softgells
Vitec
α-tocopherol
|
|
31 |
|
Melatonin |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
73-31-4 |
896 |
Synonyms:
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} acetamide
0E2B08C1-B325-45B1-8939-6F9081EFDFA4
4-ACETAMIDO-4'-ISOTHIO-CYANATOSTILBENE-2,2'-DISULFONIC ACID
5-22-12-00042 (Beilstein Handbook Reference)
5-methoxy-N-acetyltryptamine
5-Methoxy-N-acetyltryptamine
73-31-4
A4039/0172195
AB00053279
AC1L1A9Q
AC1Q4F1W
AC1Q4F1X
Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}
Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}
Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)- (9CI)
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI)
Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI)
AKOS000276269
BAS 01281092
BIDD:ER0618
Bio-0635
BPBio1_000590
BRD-K97530723-001-07-6
BRN 0205542
BSPBio_000536
BSPBio_003006
C01598
CAS-73-31-4
CCRIS 3472
CHEBI:16796
CHEMBL45
ChemDiv2_003916
CID896
Circadin
D008550
D08170
DB01065
DB08189
DivK1c_000353
EINECS 200-797-7
EU-0100787
HMS1380B22
HMS1569K18
HMS1921E04
HMS2089F09
HMS501B15
HSCI1_000400
HSDB 7509
I05-0076
I10-0345
IDI1_000353
IDI1_002631
IN1244
KBio1_000353
KBio2_000665
KBio2_003233
KBio2_005801
KBio3_002226
KBioGR_000591
KBioSS_000665
L001261
Lopac0_000787
Lopac-M-5250
LS-1623
M 5250
M1105
M-1200
M-1250
M5250_SIGMA
Melapure
Mela-T
Melatol
Melatonex
Melatonex, Melatonin
Melatonin
Melatonin (synth.) standard-grade
Melatonin (synth.) ultra-pure
Melatonina
Melatonina (TN)
Melatonine
|
Mélatonine
Melovine
ML1
MLS000859594
MLS001055382
MLS001240204
MolPort-000-737-883
MT6
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide
N-[2-(5-methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-acetamide
N-acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxytryptamine
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine melatonine
Nature'S Harmony
NCGC00015680-01
NCGC00015680-02
NCGC00015680-03
NCGC00015680-06
NCGC00015680-13
NCGC00090727-01
NCGC00090727-02
NCGC00090727-03
NCGC00090727-04
NCGC00090727-05
NCGC00090727-06
NCGC00090727-07
NCGC00090727-08
NCGC00090727-09
NCI60_004378
Night Rest
NINDS_000353
NMR/14327425
NSC 113928
NSC113928
NSC56423
Oprea1_104553
Oprea1_814234
Pineal Hormone
Posidorm
Prestwick_312
Prestwick0_000458
Prestwick1_000458
Prestwick2_000458
Prestwick3_000458
PREVENTION 1 (MELATONIN) (PREVENTION 1)
PREVENTION 2 (MELATONIN)
PREVENTION 3 (MELATONIN)
PREVENTION 4 (MELATONIN)
PREVENTION 5 (MELATONIN)
Regulin
Revital Melatonin
Rx Balance
S1204_Selleck
SDCCGMLS-0065812.P001
SDCCGMLS-0065812.P002
Sleep Right
SMP2_000309
SMR000326666
SPBio_001527
SPBio_002475
Spectrum_000185
SPECTRUM1500690
Spectrum2_001344
Spectrum3_001393
Spectrum4_000066
Spectrum5_001745
STK386880
TNP00300
UNII-JL5DK93RCL
Vivitas
WLN: T56 BMJ D2MV1 GO1
ZINC00057060
|
|
32 |
|
Tocotrienol |
Investigational |
Phase 4 |
|
6829-55-6 |
|
33 |
|
GABA Agonists |
|
Phase 4 |
|
|
|
34 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
35 |
|
Trace Elements |
|
Phase 4 |
|
|
|
36 |
|
Micronutrients |
|
Phase 4 |
|
|
|
37 |
|
Vitamins |
|
Phase 4 |
|
|
|
38 |
|
Nutrients |
|
Phase 4 |
|
|
|
39 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
40 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
41 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
42 |
|
Hydroxycholecalciferols |
|
Phase 4 |
|
|
|
43 |
|
Calciferol |
|
Phase 4 |
|
|
|
44 |
|
Tocopherols |
|
Phase 4 |
|
|
|
45 |
|
Tocotrienols |
|
Phase 4 |
|
|
|
46 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
47 |
|
Antiparasitic Agents |
|
Phase 4 |
|
|
|
48 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
49 |
|
Anesthetics |
|
Phase 4 |
|
|
|
50 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 213)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Study to Improve the Treatment of Epilepsy (SITE). A Randomized Study Comparing Adjustment of Treatment to Reduce Side Effects of Antiepileptic Drugs With Continuing Treatment Unchanged |
Unknown status |
NCT00133081 |
Phase 4 |
All registered antiepileptic drugs |
2 |
A Randomized Controlled Trial of Generic Substitution of Antiepileptic Drugs |
Unknown status |
NCT02429596 |
Phase 4 |
Experimental |
3 |
Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy |
Unknown status |
NCT02900755 |
Phase 4 |
Perampanel |
4 |
A Randomised Controlled Trial of the Ketogenic Diet in the Treatment of Epilepsy in Children Under the Age of Two Years |
Unknown status |
NCT02205931 |
Phase 4 |
Antiepileptic drug therapy |
5 |
Prospective Open Label Evaluation of Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy: A Pilot Study |
Unknown status |
NCT02726919 |
Phase 4 |
Clobazam |
6 |
Pregabalin In Partial Seizures (Preps) : An Open-Label, International, Multicenter Add-On Therapy Trial |
Completed |
NCT00141427 |
Phase 4 |
Pregabalin |
7 |
Phenytoin and Driving Safety |
Completed |
NCT00581893 |
Phase 4 |
Phenytoin |
8 |
An Open, Randomized, Multicenter Comparative Clinical Trial of Lamotrigine or Carbamazepine for Cognitive Function as Initial Monotherapy in Adult Untreated Epilepsies |
Completed |
NCT00896987 |
Phase 4 |
lamotrigine (Lamictal);Carbamazepine (Tegretol) |
9 |
A Clinical Pharmacokinetics Comparing Brand and Generic Topiramate in Epilepsy Patients : A Open-label,Randomised, Three-period Crossover Study |
Completed |
NCT02113787 |
Phase 4 |
|
10 |
EFFECT OF THREE DIFFERENT DOSES OF ORAL CHOLECALCIFEROL (1000 IU, 3000 IU AND 6000 IU DAILY) ON SERUM 25-HYDROXYVITAMIN D CHANGES AMONG EPILEPSY PATIENTS WITH HYPOVITAMINOSIS D: A RANDOMIZED PROSPECTIVE STUDY |
Completed |
NCT02890823 |
Phase 4 |
Cholecalciferol |
11 |
Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With Epilepsy |
Completed |
NCT00004637 |
Phase 4 |
Vitamin E |
12 |
Liceo Study: A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice |
Completed |
NCT00855738 |
Phase 4 |
Gabapentin, Lamotrigine, Levetiracetam, Pregabalin, Oxcarbacepine, Tiagabine, Topiramate, Zonisamide |
13 |
Lyrica (Pregabalin) Administered As An Add-On Therapy For Partial Seizures (LEADER) An Open-Label, Multicenter Add-On Therapy Trial |
Completed |
NCT00288639 |
Phase 4 |
Pregabalin |
14 |
An Open-Label, Multicenter, Multinational Study of Lacosamide as First Add-On Anti-epileptic Drug (AED) Treatment in Subjects With Partial-Onset Seizures |
Completed |
NCT00955357 |
Phase 4 |
Lacosamide |
15 |
Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Subjects With Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized Trial |
Completed |
NCT03116828 |
Phase 4 |
Eslicarbazepine acetate;Eslicarbazepine Acetate |
16 |
Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Seizure: A Randomized, add-on Placebo-controlled Clinical Trial |
Completed |
NCT03590197 |
Phase 4 |
Melatonin 3 mg |
17 |
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study) |
Completed |
NCT01733394 |
Phase 4 |
Lamotrigine Generic "A" Lamotrigine Generic "B" Lamotrigine "Brand";lamotrigine |
18 |
Women With Epilepsy: a Pilot Study of Pharmacokinetic and Pharmacodynamic Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users |
Completed |
NCT02362373 |
Phase 4 |
levonorgestrel IUS |
19 |
Searching for "Sleep Friendly" Therapies for a Sleepy Population: A Double-Blind, Placebo-Controlled, Randomized Trial to Assess the Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy |
Completed |
NCT01190098 |
Phase 4 |
Lacosamide;Placebo |
20 |
Effect of Small Changes in Plasma Valproic Acid Concentration on the Photoparoxysmal Response |
Completed |
NCT00609245 |
Phase 4 |
Valproic Acid;Placebo |
21 |
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (EQUIGEN Chronic-Dose Study) |
Completed |
NCT01713777 |
Phase 4 |
Lamotrigine Generic "A";Lamotrigine generic "B" |
22 |
Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study - |
Completed |
NCT02100644 |
Phase 4 |
Lamotrigine tablets 25/100 mg |
23 |
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial |
Completed |
NCT03052998 |
Phase 4 |
Ivermectin |
24 |
Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome, A Pilot Study |
Completed |
NCT02731300 |
Phase 4 |
|
25 |
A Shortened Antiepileptic Drug (AED) Course in Surgical Brain Tumor Patients: A Randomized Trial |
Recruiting |
NCT02334722 |
Phase 4 |
Levetiracetam extended release |
26 |
Pharmacokinetics of Antiepileptic Drugs in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy |
Recruiting |
NCT03632915 |
Phase 4 |
Levetiracetam;Lacosamide;Phenytoin;Phenobarbital;Ketamine;Valproic Acid |
27 |
Seizure Treatment IN Glioma (STING): Comparing a Treatment Strategy With Levetiracetam Versus Treatment With Valproic Acid in Glioma Patients With a First Seizure |
Recruiting |
NCT03048084 |
Phase 4 |
Levetiracetam;Valproic Acid |
28 |
Oro-dispersible Olanzapine (Wafer) Versus Conventional Oral Haloperidol or Diazepam Tablets for the Management of Acute Agitation in the Accident and Emergency Department - a Multicentre Randomised Clinical Trial |
Recruiting |
NCT03246620 |
Phase 4 |
Olanzapine oro-dispersible 5Mg Tab;Haloperidol 2Mg encapsulated Tab;Diazepam 2Mg encapsulated Tab |
29 |
Efficacy and Tolerability of Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy (STANDLOW). A Multicenter, Randomized, Single-blind, Parallel-group Trial |
Not yet recruiting |
NCT03689114 |
Phase 4 |
Low dose carbamazepine;Standard dose carbamazepine;Low dose levetiracetam;Standard dose levetiracetam;Low dose valproate;Standard dose valproate;Low dose zonisamide;Standard dose zonisamide;Low dose oxcarbazepine;Standard dose oxcarbazepine;Low dose topiramate;Standard dose topiramate;Low dose lamotrigine;Standard dose lamotrigine;Low dose gabapentin;Standard dose gabapentin |
30 |
Post Marketing Study; Randomized, Parallel-Group Comparison of Treatment With Pharmacotherapy or Adjunctive Vagus Nerve Stimulation Therapy for Pharmacoresistant Partial Seizures: A Large Simple Effectiveness Trial |
Terminated |
NCT00215215 |
Phase 4 |
|
31 |
An Open Randomized Trial to Assess the Efficacy and Safety of Vagus Nerve Stimulation (VNS) Versus New Anti-Epileptic Drug (AED) Treatment in Children With Refractory Seizures |
Terminated |
NCT01118455 |
Phase 4 |
Anti-Epileptic Drug (AED) |
32 |
A Randomised, Double Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability and to Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures |
Terminated |
NCT01546688 |
Phase 4 |
Zonisamide at targeted daily doses of 100-500 mg/day;Placebo administered to match targeted daily doses of 100-500 mg/day |
33 |
An Open Label, Randomized Study Prospectively Examining the Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin |
Terminated |
NCT01128712 |
Phase 4 |
Pregabalin;Pregabalin |
34 |
Evaluating Transporter Protein Inhibitors in Patients With Epilepsy |
Terminated |
NCT00610532 |
Phase 4 |
phenytoin;phenytoin and probenecid |
35 |
Sabril for Treatment of Adult Refractory Partial Seizures Symptomatic of Tuberous Sclerosis: An Open Label, Phase IV Prospective Safety and Tolerability Study |
Terminated |
NCT01266291 |
Phase 4 |
vigabatrin |
36 |
Lexapro for Major Depression in Patients With Epilepsy |
Terminated |
NCT01244724 |
Phase 4 |
Lexapro |
37 |
Efficacy Study of Folic Acid Supplementation on Homocysteine Levels in Adolescent Epileptics Taking Antiepileptic Drugs: A Single Blind Randomized Controlled Clinical Trial |
Unknown status |
NCT02318446 |
Phase 3 |
Folic Acid;Saccharine |
38 |
A Randomised Controlled Trial in the Palliative Setting Regarding Off-Label Medication: Investigating the Efficiency of Amitriptyline Versus Pregabalin From a Societal Perspective |
Unknown status |
NCT00740571 |
Phase 3 |
amitriptyline;pregabalin |
39 |
Multicenter, Comparative, Randomized, Open Trial to Evaluate Efficacy and Safety of Levetiracetam Versus Carbamazepine in Post Stroke Late Onset Crisis |
Unknown status |
NCT00542802 |
Phase 3 |
Levetiracetam;Carbamazepine |
40 |
Double Blind Placebo Controlled Trial of Anticonvulsant Effects of n-3 PUFAs in Human Subjects With Epilepsy |
Unknown status |
NCT01769092 |
Phase 2, Phase 3 |
|
41 |
A Double-Blind, Randomized, Placebo-Controlled Intervention Study of the Efficacy and Safety of "NFM proBio65" in the Atopic and Allergic Volunteers |
Completed |
NCT00893230 |
Phase 3 |
|
42 |
A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment in Pediatric Subjects 1 to Less Than 4 Years of Age With Inadequately Controlled Lennox-Gastaut Syndrome |
Completed |
NCT01405053 |
Phase 3 |
Rufinamide;Any other approved Antiepileptic Drug |
43 |
Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study |
Completed |
NCT01823159 |
Phase 3 |
retigabine;placebo |
44 |
An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients With Partial Seizures |
Completed |
NCT00522275 |
Phase 3 |
lacosamide |
45 |
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method |
Completed |
NCT00160615 |
Phase 3 |
Levetiracetam |
46 |
Topiramate (RWJ 17021-000) Clinical Trial In Children With Partial Onset Seizures |
Completed |
NCT00236743 |
Phase 3 |
topiramate |
47 |
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures |
Completed |
NCT00292461 |
Phase 3 |
Zonisamide;Lamotrigine |
48 |
Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs |
Completed |
NCT00866775 |
Phase 3 |
Eslicarbazepine acetate;Eslicarbazepine acetate |
49 |
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures |
Completed |
NCT01284556 |
Phase 3 |
Phenobarbital;Placebo tablet |
50 |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study to Determine the Efficacy and Safety of Retigabine (1200 mg/Day) Used as Adjunctive Therapy in Refractory Epilepsy Patients With Partial-Onset Seizures |
Completed |
NCT00232596 |
Phase 3 |
Retigabine;Placebo |
|